CONCLUSION
Our study has shown an association between higher MAGE and women who subsequently develop GDM. Our study demonstrated the use of the CGM sensor during pregnancy to be a promising, and applicable technology in gestational glucose profiling to determine GV and GC parameters in a convenient, and pain-free manner. Early pregnancy presents a unique opportunity for early GDM risk stratification to allow for earlier lifestyle interventions to prevent adverse maternal and child health outcomes 27. More future studies are required on a larger scale to eventually establish a gold standard metric using CGM-derived data in terms of predicting the risk for GDM development.